TY  - JOUR
AU  - Ruggeri, Annalisa
AU  - Galimard, Jacques-Emmanuel
AU  - Paina, Olesya
AU  - Fagioli, Franca
AU  - Tbakhi, Abdelghani
AU  - Yesilipek, Akif
AU  - Navarro, Jose Maria Fernandez
AU  - Faraci, Maura
AU  - Hamladji, Rose-Marie
AU  - Skorobogatova, Elena
AU  - Al-Seraihy, Amal
AU  - Sundin, Mikael
AU  - Herrera, Concepcion
AU  - Rifon, Jose
AU  - Dalissier, Arnaud
AU  - Locatelli, Franco
AU  - Rocha, Vanderson
AU  - Corbacioglu, Selim
PY  - 2021
DO  - 10.1016/j.jtct.2021.01.016
UR  - http://hdl.handle.net/10668/17765
T2  - Transplantation and cellular therapy
AB  - HLA-haploidentical transplantation (haplo-HCT) using post-transplantation-cyclophosphamide (PT-Cy) is a feasible procedure in children with malignancies. However, large studies on Haplo-HCT with PT-Cy for childhood acute lymphoblastic leukemia (ALL)...
LA  - en
PB  - Elsevier
KW  - Acute lymphoblastic leukemia
KW  - Childhood
KW  - Haploidentical transplantation
KW  - Post-transplantation cyclophosphamide
KW  - Child
KW  - Cyclophosphamide
KW  - Humans
KW  - Precursor cell lymphoblastic leukemia-lymphoma
KW  - Retrospective studies
KW  - Transplantation conditioning
KW  - Transplantation, haploidentical
TI  - Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia.
TY  - research article
VL  - 27
ER  -